[Form 4] Douglas Elliman Inc. Insider Trading Activity

Rhea-AI Filing Summary

Douglas Elliman Inc. reported an equity grant to a director-level insider. On November 26, 2025, the company granted the reporting person a restricted stock award of 58,594 shares of Douglas Elliman common stock under its 2021 Management Incentive Plan. The award was reported as acquired at a price of $0, reflecting that it is a compensatory grant rather than an open-market purchase.

The restricted stock will vest in two equal annual installments on November 26, 2026 and November 26, 2027, as long as the reporting person continues in service through each vesting date. The grant may vest earlier if the reporting person dies, becomes disabled, or if there is a change of control at the company. Following this transaction, the reporting person beneficially owns 58,594 shares of Douglas Elliman common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weitz Perry

(Last) (First) (Middle)

C/O DOUGLAS ELLIMAN INC.

4400 BISCAYNE BLVD.; 10TH FLOOR

(Street)

MIAMI FL 33137

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Douglas Elliman Inc. [ DOUG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		A		58,594(1)	A	$0(1)	58,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On November 26, 2025 the Issuer granted the Reporting Person a restricted stock award of 58,594 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of November 26, 2026 and November 26, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

Remarks:

Exhibit 24 - Limited Power of Attorney, dated November 3, 2025, filed with Form 3 on November 7, 2025.

	/s/ J Bryant Kirkland III, Attorney in Fact for Perry Weitz	11/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Douglas Elliman Inc. (DOUG) report on this Form 4?

Douglas Elliman Inc. reported that a director-level insider received a restricted stock award of 58,594 shares of the company’s common stock on November 26, 2025 under the 2021 Management Incentive Plan.

What are the vesting terms of the 58,594 restricted shares reported by DOUG?

The 58,594 restricted shares will vest in two equal annual installments on November 26, 2026 and November 26, 2027, subject to the reporting person’s continued service, with potential earlier vesting upon death, disability, or a change of control.

Was the Douglas Elliman (DOUG) restricted stock grant an open-market purchase?

No. The grant was reported at a price of $0 per share, indicating it was a compensatory restricted stock award under the company’s 2021 Management Incentive Plan, not an open-market purchase.

How many Douglas Elliman (DOUG) shares does the reporting person own after this transaction?

After the restricted stock grant, the reporting person beneficially owns 58,594 shares of Douglas Elliman common stock, held directly.

What role does the reporting person have at Douglas Elliman Inc. (DOUG)?

The reporting person is identified as a Director of Douglas Elliman Inc., as indicated in the relationship section of the filing.

Under which plan was the Douglas Elliman (DOUG) restricted stock award granted?

The restricted stock award of 58,594 shares was granted under Douglas Elliman Inc.’s 2021 Management Incentive Plan.